Full Breakdown
ASHG Hosts Genetic Diagnosis & Rare Disease Virtual Symposium
11/23/2025, 12:18:02 PM
Overview of the Symposium
The American Society of Human Genetics (ASHG) is set to host the Genetic Diagnosis & Rare Disease Virtual Symposium on December 2-3, 2023. This event aims to address the lengthy diagnostic journeys that many rare disease patients endure, often spanning years. By leveraging advanced methodologies such as long-read sequencing, RNA-Seq, and federated variant sharing, the symposium seeks to enhance accessibility to cutting-edge genetic technologies for professionals worldwide.
Objectives and Features
ASHG's initiative is part of a broader strategy to ensure continuous learning in the rapidly evolving fields of genetics and genomics. The virtual format of the symposium is designed to eliminate barriers to knowledge, fostering collaboration among researchers and healthcare professionals. Over the two-day event, participants will have the opportunity to attend 16 presentations led by prominent experts in rare disease diagnosis and genomic technologies. Each session will include interactive Q&A segments, allowing for direct engagement with the speakers.
Professional Development Opportunities
Attendees of the symposium can earn up to six Continuing Medical Education (CME) credits, reflecting ASHG's commitment to professional development alongside scientific progress. Keynote speakers include Kiran Musunuru, MD, PhD, MPH, and Rebecca Ahrens-Nicklas, MD, PhD, who will discuss personalized gene editing therapy. Additionally, Helene Cederroth, PhD, and Eric Klee, PhD, will present on the Undiagnosed Hackathon, a collaborative initiative aimed at solving complex cases for individuals with undiagnosed conditions.
Importance of the Symposium
The symposium represents a significant step in improving patient outcomes and accelerating discovery in the field of rare diseases. By providing a platform for sharing knowledge and expertise, ASHG aims to empower professionals to stay abreast of emerging technologies that can enhance diagnostic processes and treatment options.
Official Statements & Responses
Elisha Roberson, PhD, Chair of the Digital Learning Committee at ASHG, emphasized the importance of the symposium in the context of ongoing education in genetics. He stated that the event is a cornerstone of ASHG's strategy to reduce barriers to knowledge and foster collaboration among professionals in the field.
Criticism & Opposition
While the symposium aims to enhance accessibility to genetic technologies, some critics argue that virtual formats may not fully replicate the networking opportunities and hands-on experiences provided by in-person events. This perspective highlights the ongoing debate about the effectiveness of digital learning environments in specialized fields.
What's Next
Following the symposium, ASHG plans to continue its efforts in creating a robust digital ecosystem that includes webinars, workshops, and podcasts, ensuring that the global research community remains informed about the latest advancements in genetics and genomics throughout the year.
